In this article from November 2019, Cardiff University’s School of Pharmacy and Pharmaceutical Sciences describes the early stages of their research to find a way to deliver a chemical product that bypasses the faulty enzyme caused by a mutation in the GNE gene and re-estblish the body’s production of sialic acid.
Read the full story from Cardiff University and access the research here.
NDF’s goal is to provide an accessible website to all. While we work to remove barriers that prevent persons with disabilities from accessing information made available on our website, we offer phone support in several languages. Please call 1-(310) 721-1605 or click here to request a call back.
The Neuromuscular Disease Foundation is a 501(c)(3) nonprofit organization
EIN: 06-1789643
Please be advised that content within the NDF website includes a compilation of material from differing sources. NDF does not provide medical advice nor is NDF a medical provider. This content is intended for informational purposes. Please contact your health care provider(s) for your specific healthcare needs. The NDF website contains links to external websites that are not in any way affiliated with NDF. NDF suggests that you review the terms of service and privacy policies of these websites before using them. Please note that NDF does not guarantee the accuracy, relevance, timeliness, or completeness of any information on these external websites.
